The purpose of the ARLG Mentoring Program is to develop the next generation of clinician scientists in antimicrobial resistance (AR). The Mentoring Program is directed towards the career-development of trainees at the fellow (ARLG Fellow) and junior faculty (ARLG Early Stage Investigator, ESI) level. This program will focus on three key elements that are critical to success in clinical and translational research as it pertains to antimicrobial resistance:
- Mentorship by established investigator(s)
- Mentor-Mentee driven research project focused on AR
- Training in research core competencies
Each of these three elements will be tailored to the career-level (i.e., fellow vs. ESI) and specific interests (e.g., gram-negative bacterial resistance vs. infection control strategies) of the mentee. K-scholars, defined as trainees funded by Career Development Awards (e.g. K08, K23 or equivalent foundation award) will particularly be encouraged to participate. For each approved K-scholar, we will work with the program officer for their K-award, their mentor, and the ARLG program official to ensure coordination of efforts and appropriate overlap of activities. In addition, mentees will gain practical experience in research management and team science by being integrated into the ARLG leadership for the duration of their tenure.
Completion of an AR project is a requirement for each ARLG fellow and ESI. Projects may be proposed ‘de novo’ from the trainee or selected among the list of high priority mentor/mentee projects. It is critical that the trainee be paired with the appropriate mentor for the proposed AR project in order to optimize the mentorship and research experience. From this research experience, the trainee is expected to produce at least one first-author publication in a high impact peer-reviewed journal.